Improved transplant outcomes in the modern era

Contemporary autologous stem cell transplant series show 10-year overall survival approaching 80%, with transplant-related mortality decreasing to 2-5%. Better patient selection, supportive care, and pre-transplant debulking with bortezomib or lenalidomide have contributed to improved outcomes.